Clinical Trials in Austin

Showing 4001-4020 of 15,205 trials

AVID100 in Advanced Epithelial Carcinomas

NCT03094169

Approximately 90 male and female patients with documented solid tumor malignancies of epithelial origin that are locally advanced or metastatic, and either refractory to standard therapy or for whom no standard therapy is available, will be entered into this Phase 1a/2a, multicenter, open-label, dose-escalation, cohort study of AVID100. Phase 2a will include evaluation of patient with EGFR-overexpressing squamous histology non-small cell lung cancer, squamous cell carcinoma of the head and neck, and triple negative breast cancer

Solid Tumor, AdultTriple Negative Breast CancerHead and Neck Squamous Cell Carcinoma+1 more

Formation Biologics49 participantsStarted Feb 2017

New Haven, Connecticut, United States • Grand Rapids, Michigan, United States • New York, New York, United States +7 more locations

Active Not RecruitingNA< 1 mile

ProVIDE II Bridging Study

NCT06236802

The purpose of the ProVIDE II Bridging Study is to evaluate the performance of the Generation II delivery system when deploying the ProVee expander in subjects with symptomatic urinary obstruction secondary to BPH.

BPH With Symptomatic Lower Urinary Tract Symptoms

ProVerum Medical40 participantsStarted Mar 2024

Tampa, Florida, United States • Winter Garden, Florida, United States • Lake Barrington, Illinois, United States +5 more locations

AVID100 in Advanced Epithelial Carcinomas

ProVIDE II Bridging Study

Find Trials by Condition in Austin

An Evaluation of the Safety of CSF-1 in Presbyopic Subjects

Microfragmented Adipose Tissue Compared to Saline Injection for the Treatment of Knee Osteoarthritis

A 52-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough

VB-111 in Surgically Accessible Recurrent/Progressive GBM

Alzheimer's Plasma Extension

Study of NKTR 255 in Combination With Cetuximab in Solid Tumors

A Study to Investigate Efficacy and Safety of VTAMA (Tapinarof) Cream, 1% in Intertriginous Plaque Psoriasis

Evaluate the Effect of Obicetrapib in Patients With HeFH on Top of Maximum Tolerated Lipid-Modifying Therapies.

JAGUAR Trial: ObJective Analysis to GaUge EVAR Outcomes Through Randomization

TRIcvalve biCAVal Valve System for Severe Tricuspid Regurgitation (TRICAV-I)

Study of Orally Administered AG-120 in Subjects With Advanced Hematologic Malignancies With an IDH1 Mutation

Medical Access Program for Patritumab Deruxtecan

Nemvaleukin Alfa Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Cutaneous or Mucosal Melanoma - ARTISTRY-6

Study of the Efficacy and Safety PF-06741086 in Adult and Teenage Participants With Severe Hemophilia A or Moderately Severe to Severe Hemophilia B

Long-Term Safety and Antibody Persistence of TDV and the Impact of a Booster Dose

A Study ATG-101 in Patients With Metastatic/Advanced Solid Tumors and Mature B-cell Non-Hodgkin Lymphomas

Study of Neoadjuvant Olaparib Monotherapy and Olaparib and Durvalumab Combination in HER2 Negative BRCAm Breast Cancer

Study to Evaluate Safety and Immunogenicity of a Prime-Boost Regimen of rVSV-Nipah Virus Vaccine Candidate PHV02 in Healthy Adult Subjects